BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14117417)

  • 1. EFFECTS OF INTRAVENOUS INFUSIONS OF FEATHER KERATIN: PRELIMINARY CHARACTERIZATION AND EVALUATION AS A PLASMA EXPANDER.
    EWALD RA; ANDERSON P; WILLIAMS HL; CROSBY WH
    Proc Soc Exp Biol Med; 1964 Jan; 115():130-3. PubMed ID: 14117417
    [No Abstract]   [Full Text] [Related]  

  • 2. CIRCULATORY RESPONSES TO INTRAVENOUS INFUSIONS OF HYDROXYETHYL STARCH SOLUTIONS.
    THOMPSON WL; WALTON RP
    J Pharmacol Exp Ther; 1964 Dec; 146():359-64. PubMed ID: 14254330
    [No Abstract]   [Full Text] [Related]  

  • 3. PLASMA VOLUME EXPANSION BY RAPID INFUSION OF A LOW MOLECULAR WEIGHT DEXTRAN.
    DAVIES JW; RICKETTS CR; WILLIAMS BN
    Br J Pharmacol Chemother; 1963 Oct; 21(2):220-5. PubMed ID: 14081651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ON THE POSSIBILITIES OF USING NON-CITRATED ERYTHROCYTE MIXTURES FOR TOTAL BLOOD SUBSTITUTION IN ANIMALS].
    GUTNIK RB
    Eksp Khir Anesteziol; 1963; 18():90-2. PubMed ID: 14053095
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraportal and intravenous infusion of casein hydrolysate. Comparative studies of the plasma proteins and microscopic liver changes in dogs. Preliminary report.
    HOLM I
    Acta Chir Scand; 1962 Aug; 124():127-33. PubMed ID: 13908489
    [No Abstract]   [Full Text] [Related]  

  • 6. STUDIES ON THE STRUCTURE OF FEATHER KERATIN. IV. SOLUBILIZATION EFFECTS OF MERCURIC SALTS.
    TIFFANY ML; KRIMM S
    J Mol Biol; 1964 Nov; 10():199-201. PubMed ID: 14235580
    [No Abstract]   [Full Text] [Related]  

  • 7. Beyond plucking: Feathers bioprocessing into valuable protein hydrolysates.
    Callegaro K; Brandelli A; Daroit DJ
    Waste Manag; 2019 Jul; 95():399-415. PubMed ID: 31351626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE RENAL AND SYSTEMIC EFFECTS OF HYDROXYETHYL STARCH SOLUTION INFUSIONS.
    MURPHY GP; DEMAREE DE; GAGNON JA
    J Urol; 1965 May; 93():534-9. PubMed ID: 14290403
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of feather hydrolysates with antioxidant, angiotensin-I converting enzyme- and dipeptidyl peptidase-IV-inhibitory activities.
    Fontoura R; Daroit DJ; Correa AP; Meira SM; Mosquera M; Brandelli A
    N Biotechnol; 2014 Sep; 31(5):506-13. PubMed ID: 25038398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Utilization by the human organism of components of intravenous protein hydrolysates].
    TOCZKO K; CHMIELEWSKA I
    Acta Physiol Pol; 1962; 13():489-99. PubMed ID: 13985235
    [No Abstract]   [Full Text] [Related]  

  • 11. THE PHYSIOLOGIC PROPERTIES OF GLYCO-ALGINATE, A NEW JAPANESE PLASMA-VOLUME EXPANDER.
    MURPHY GP; MUNDY RL; EWALD RA
    Surgery; 1964 Dec; 56():1099-108. PubMed ID: 14238365
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical picture and experimental studies on anemia in paraplegia].
    Franke D; Hartung H; Schröder F
    Langenbecks Arch Chir; 1968; 322():605-9. PubMed ID: 5758780
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental and clinical study of a plasma expander (hydroxyethyl starch)--comparison with dextran 70 and MF-gelatine].
    Goto Y; Kimura H; Matsumoto K; Yamahara T; Nagata M
    Masui; 1971 Nov; 20(12):1114-23. PubMed ID: 5169830
    [No Abstract]   [Full Text] [Related]  

  • 14. FLUID THERAPY IN HEMORRHAGIC SHOCK.
    SHIRES T; COLN D; CARRICO J; LIGHTFOOT S
    Arch Surg; 1964 Apr; 88():688-93. PubMed ID: 14107023
    [No Abstract]   [Full Text] [Related]  

  • 15. LABORATORY EXPERIENCE WITH 24 HOUR PARTIAL HEART-LUNG BYPASS.
    GALLETTI PM
    J Surg Res; 1965 Mar; 5():97-104. PubMed ID: 14273770
    [No Abstract]   [Full Text] [Related]  

  • 16. MANAGEMENT OF DROWNING VICTIMS.
    REDDING JS; PEARSON JW
    GP; 1964 Jun; 29():100-4. PubMed ID: 14143820
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of a novel antioxidant peptide from feather keratin hydrolysates.
    Fontoura R; Daroit DJ; CorrĂȘa APF; Moresco KS; Santi L; Beys-da-Silva WO; Yates JR; Moreira JCF; Brandelli A
    N Biotechnol; 2019 Mar; 49():71-76. PubMed ID: 30223040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of blood and colloids in the newborn.
    Sacks HJ
    Pediatr Clin North Am; 1969 Aug; 16(3):593-600. PubMed ID: 5808148
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemoglobin II immunogenic properties of stroma vs. stroma-free hemoglobin solution.
    Cochin A; Das Gupta TK; DeWoskin R; Moss GS
    J Surg Oncol; 1974; 6(1):19-28. PubMed ID: 4132073
    [No Abstract]   [Full Text] [Related]  

  • 20. [Behavior of dog thrombocytes in the blood circulation system during infusions with colloidal blood substitutes].
    Wellmer HK
    Langenbecks Arch Chir; 1968; 322():1194-8. PubMed ID: 5758708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.